The role of the pharmacist in ensuring safety of CAR T-cell therapy

As chimeric antigen receptor (CAR) T-cell therapies are patient-specific, this novel treatment type poses unique challenges. From the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018... Author: VJOncology Added: 10/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts